DYVOX Dynavox Group AB (publ)

7.471USD75.90 SEK · STO+2.36%Mkt Cap: 792.39M USDP/E: 29.65

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and a…

Institutional holders11 on file

Key Statistics

Company
Market Cap792.39M USD
Enterprise Value885.61M USD
Revenue (TTM)257.79M USD
Gross Profit166.17M USD
Net Income (TTM)16.31M USD
Revenue/Share2.44 USD
Last Price7.471 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.1K
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0017105620
Valuation
P/E (Trailing)29.65
P/E (Forward)36.14
PEG—
EV/EBITDA17.20
EV/Revenue3.44
P/S3.07
P/B9.85
EPS (TTM)0.25 USD
EPS (Forward)0.21 USD
52W Range
5.63039% of range10.38
52W High10.38 USD
52W Low5.630 USD
Profitability
Gross Margin68.43%
Oper. Margin16.31%
EBITDA Margin19.97%
Profit Margin6.72%
ROE27.51%
ROA6.70%
ROIC14.44%
ROCE15.27%
Growth
Revenue Growth13.00%
Earnings Growth137.10%
Cash Flow & Leverage
Operating CF19.35M USD
CapEx (TTM)20.17M USD
FCF Margin6.95%
FCF Yield2.26%
Net Debt81.50M USD
Net Debt/EBITDA1.58
Net Debt/FCF4.55
Balance Sheet
Debt/Equity1.83
Current Ratio1.71
Quick Ratio1.20
Book Value/Sh0.76 USD
Cash/Share0.25 USD
Dividends
Fwd Div Rate0.05 USD
Trail. Div Rate0.05 USD
Div. Yield0.67%
5Y Avg Yield—
Payout Ratio19.38%
Ex-Div DateMay 11, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)10.90 USD
Upside (mean)+45.9%
Target Range8.859 USD – 13.58 USD
8.859+45.9% to mean13.58
# Analysts4
Ownership
Shares Out.106.07M
Float101.37M
Insiders4.34%
Institutions73.81%
Technical
SMA 507.429 (+0.6%)
SMA 2007.578 (-1.4%)
Beta0.81
S&P 52W Chg12.00%
Avg Vol (30d)444.71K
Avg Vol (10d)272.37K
Technical Indicators
RSI (14)53.5
MACD-0.5146
MACD Signal-0.8968
MACD Hist.+0.3823
BB Upper7.482 USD
BB Middle7.185 USD
BB Lower6.887 USD
BB Width8.28%
ATR (14)0.3253 USD
Vol Ratio (20d)0.58x

About Dynavox Group (STO: DYVOX)

›

Dynavox Group (STO: DYVOX) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 1,107 employees.

The shares were at 75.90 SEK on 19 November 2026, down 17.9% over 52 weeks. Its 52-week range is 57.20 SEK to 105.50 SEK: the price is 28.1% below the high and 32.7% above the low.

At a market capitalisation of 8.05B SEK, it trades at 29.6 times trailing earnings and 36.1 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 40% for DYVOX. It pays a dividend yielding 0.67% (it pays out 19% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Dynavox Group reports return on equity of 27.5%, an operating margin of 16.3% and revenue up 13.0% year over year.

Its debt exceeds its cash by 828.00M SEK, a debt-to-equity ratio of 1.83. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 110.75 SEK is 45.9% above the current price. The next earnings report is expected on 4 February 2027.